Charani Ranasinghe
Australian National University(AU)
Publications by Year
Research Areas
Immune Cell Function and Interaction, Immunotherapy and Immune Responses, HIV Research and Treatment, T-cell and B-cell Immunology, IL-33, ST2, and ILC Pathways
Most-Cited Works
- → Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial(2021)117 cited
- → Isolation and characterization of two cytochrome P450 cDNA clones for CYP6B6 and CYP6B7 from Helicoverpa armigera (Hubner): possible involvement of CYP6B7 in pyrethroid resistance(1998)90 cited
- → Mucosal HIV-1 Pox Virus Prime-Boost Immunization Induces High-Avidity CD8+ T Cells with Regime-Dependent Cytokine/Granzyme B Profiles(2007)81 cited
- → IL-4 and IL-13 receptors: Roles in immunity and powerful vaccine adjuvants(2014)80 cited
- → A DNA prime‐live vaccine boost strategy in mice can augment IFN‐γ responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis(2003)72 cited
- → Mucosally-administered human–simian immunodeficiency virus DNA and fowlpoxvirus-based recombinant vaccines reduce acute phase viral replication in macaques following vaginal challenge with CCR5-tropic SHIVSF162P3(2005)62 cited
- → Role of novel type I interferon epsilon in viral infection and mucosal immunity(2012)62 cited
- → Preclinical development of a molecular clamp‐stabilised subunit vaccine for severe acute respiratory syndrome coronavirus 2(2021)61 cited
- → Evaluation of fowlpox–vaccinia virus prime-boost vaccine strategies for high-level mucosal and systemic immunity against HIV-1(2006)55 cited
- → Genetic heterologous prime–boost vaccination strategies for improved systemic and mucosal immunity(2009)49 cited